Amie Sims Rainey, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3062 Main St, Pikeville, TN 37367 Phone: 423-447-2955 Fax: 423-447-2405 |
Larry Bruce Compton, APRN, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 344 Church St, Pikeville, TN 37367 Phone: 423-447-2992 |
Mrs. Kayla Tanyee Perry, MSN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3625 Main St, Pikeville, TN 37367 Phone: 423-447-6287 |
Clara Amanda Johnson, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1045 Horsehead Ln, Pikeville, TN 37367 Phone: 423-881-6358 |
Ashley Mae Tibbetts, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3625 Main St, Pikeville, TN 37367 Phone: 423-447-6287 |
Desiree Cadell Brock-hudson, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3062 Main St, Pikeville, TN 37367 Phone: 423-447-2955 |
Ms. Ruth Ellen Boynton, NURSE PRACTITIONER Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3062 Main St, Pikeville, TN 37367 Phone: 423-447-2955 Fax: 423-447-2405 |
News Archive
Micell Technologies,â„¢ Inc. today announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries) clinical trial. Stefan Verheye, M.D., Ph.D. at Middelheim Hospital, Antwerp, Belgium enrolled the first patient in the study. This clinical investigation is being conducted to support CE Mark approval of the company's MiStentâ„¢ Drug-Eluting Coronary Stent System (MiStent DES).
A modest increase in the number of skilled midwives in the world's poorest nations could save the lives of a substantial number of women and their babies, according to new analyses by researchers from the Johns Hopkins Bloomberg School of Public Health.
Cancer researchers have discovered that a type of regulatory RNA may be effective in fighting ovarian cancer. Ovarian cancer isn't typically discovered until it's in the advanced stages, where it is already spreading to other organs and is very difficult to fight with chemotherapy.
Fungal infections represent an increasing health crisis, especially for immune-deficient patients. American scientists now report in the journal Angewandte Chemie that specific help could be provided by small-molecule immunotherapeutics with novel mechanism of action.
› Verified 8 days ago